SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-315955
Filing Date
2020-12-11
Accepted
2020-12-11 16:42:57
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d23719ds3.htm S-3 203183
2 EX-5.1 d23719dex51.htm EX-5.1 5961
3 EX-23.1 d23719dex231.htm EX-23.1 1733
4 EX-23.2 d23719dex232.htm EX-23.2 1570
5 EX-23.3 d23719dex233.htm EX-23.3 1903
6 GRAPHIC g23719g1203092158289.jpg GRAPHIC 2695
7 GRAPHIC g23719g1203092158523.jpg GRAPHIC 4334
8 GRAPHIC g23719g36l34.jpg GRAPHIC 2414
  Complete submission text file 0001193125-20-315955.txt   228910
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251305 | Film No.: 201383972
SIC: 2834 Pharmaceutical Preparations